NOVELTY NOBILITY
Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role. In ophthalmology, Novelty Nobility first discovered a novel angiogenesis target, Stem Cell Factor(SCF) and c-KIT, which was initially known for its engagement with proliferation and survival of primitive hematopoietic stem cells for a couple of past decad... es. We believe that anti-SCF/c-KIT could effectively address the unmet medical needs, mostly caused by inherent limitations of anti-VEGFs, in terms of treatment efficacy and long-term safety. Our target discovery is widely and strongly patent-protected in US/KOR and the lead pipeline, NN2101(a full-human monoclonal antibody), is currently under preclinical development.
NOVELTY NOBILITY
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2017-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.noveltynobility.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Euro Google Maps JQuery CDN Pound Sterling Japanese Yen
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Official Site Inspections
http://www.noveltynobility.com
- Host name: 58.230.162.239
- IP address: 58.230.162.239
- Location: Daegu South Korea
- Latitude: 35.8723
- Longitude: 128.5924
- Timezone: Asia/Seoul
- Postal: 41934
More informations about "Novelty Nobility"
Novelty Nobility - Crunchbase Company Profile
Contact Email [email protected] Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in …See details»
Novelty Nobility Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Novelty Nobility. Use the PitchBook Platform to explore the full profile.See details»
Novelty Nobility Inc. Information - RocketReach
Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and Boston, Massachusetts. We are currently focused on the research of novel angiogenesis …See details»
Novelty Nobility Inc. - LinkedIn
Novelty Nobility will be presenting at the American Association for Cancer Research (AACR) Annual Meeting 2024 on April 8th in San Diego, CA. Stop by our poster for further preclinical …See details»
NOVELTY NOBILITY Inc.
Sang Gyu is the founder and CEO of Novelty Nobility and a senior scientist with 25 years of experience in protein and antibody research. Up to now, he has designed more than 200 …See details»
Novelty Nobility Inc. Overview | SignalHire Company Profile
Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and Boston, Massachusetts. We are currently focused on the research of novel angiogenesis …See details»
Novelty Nobility Inc. | LinkedIn
Novelty Nobility Inc. | 399 followers on LinkedIn. Novel Science, Noble Management | Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and …See details»
Novelty Nobility - VentureRadar
Novelty Nobility Inc. is a private biotech company located in Pangyo and Ajou University, South Korea. We specialize in the discovery, optimization... ... Find out ...See details»
Novelty Nobility - Portfolio Company Profile, Executives and …
See Novelty Nobility's complete profile, including its private equity owner and the number of its executive contacts in our database. Novelty Nobility Inc. is a private biotech company, …See details»
Novelty Nobility - Products, Competitors, Financials, Employees ...
Noveltynobility.com. Overview & Products; Financials; People; Founded Year 2017. Stage Series C | Alive. Total Raised $58.77M. Last Raised $16.67M | 19 days ago. About Novelty Nobility. …See details»
Novelty Nobility - Company Profile - Tracxn
Nov 27, 2024 Email ID: *****@noveltynobility.com; Key Metrics. Total Funding. $8.37M in 1 round. Latest Funding Round. Series A, Feb 04, 2020, $8.37M. Investors. Shinhan Venture …See details»
Novelty Nobility - Crunchbase Company Profile & Funding
Novelty Nobility is a private biotech company focused on the research of novel angiogenesis targets and develop antibody-based therapeutics.See details»
Novelty Nobility - Overview, News & Similar companies - ZoomInfo
Feb 15, 2022 www.noveltynobility.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Korean Bioventures Suffer Q2 Financing …See details»
Novelty Nobility - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Novelty Nobility - Tech Stack, Apps, Patents & Trademarks
Dec 10, 2024 Novelty Nobility is a private biotech company focused on the research of novel angiogenesis targets and develop antibody-based therapeutics.See details»
Invest In Novelty Nobility Stock | Buy Pre-IPO Shares - EquityZen
Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and …See details»
Novelty Nobility - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
Novelty Nobility, Inc. (Novelty Nobility, Inc.) - 药物管线_专利_临床 …
了解Novelty Nobility, Inc. (Novelty Nobility, Inc.)公司的药物管线，治疗领域，技术平台，以及它的5篇新闻，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统疾病，内分泌与代谢疾病，技术平 …See details»
Novelty Nobility’s auto-immune disease candidate NN2802 gets
Feb 13, 2023 Novelty Nobility, a Korean company specializing in antibody new drug development, said on Monday that its U.S. partner, ValenzaBio, was acquired by Acelyrin on …See details»
Novelty Nobility-动脉网 - vbdata.cn
Jan 1, 2017 Novelty Nobility Inc. 是一家私营生物技术公司，位于韩国板桥和亚洲大学。我们深入了解什么是好的抗体、它是如何制造的以及我们可以用它做什么来改善患者的生活。我们专注 …See details»